Post-earnings recap
Reported
Tue, May 7, 2019
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Haemonetics Corp's earnings report shows a positive surprise in EPS, which led to a 4.4% increase in stock price. The lack of revenue figures may raise questions among investors, but management's focus on profitability and operational efficiency could be seen as a positive sign. Overall, the market reacted favorably to the earnings beat.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.61 | N/A | +6.50% |
| Revenue | N/A | N/A | N/A |
Management is pleased with the EPS results, indicating a focus on maintaining profitability. However, they did not provide specific revenue guidance.
Management expressed satisfaction with the EPS performance despite not providing revenue figures.
They highlighted ongoing efforts to improve operational efficiency.